Virtify Successfully Completes Disclosure Implementations

News provided by

Apr 26, 2011, 02:47 ET

CAMBRIDGE, Mass., April 26, 2011 /PRNewswire/ -- Virtify, Inc., a leader in providing comprehensive clinical trial disclosure solutions, has announced two successful implementations of its clinical trial disclosure software, Virtify CTRR, in the first quarter of 2011.

(Logo: http://photos.prnewswire.com/prnh/20110131/NE38689LOGO )

Virtify's software development methodology for delivering highly configurable software solutions has enabled rapid implementation of new software and updates. This approach significantly improves return on investment over traditional custom software deployments. Virtify's 5-step implementation plan has enabled customers to implement fully validated software in as little as 8 weeks.

"Customers today want choices in how they scope, configure and deploy their disclosure software, without the need of customizing the software," said Satish Tadikonda, President and CEO of Virtify, Inc. "Virtify CTRR offers customers a new model for their clinical trial disclosure software, with an emphasis on time-to-value, while still retaining the flexibility to expand the solution to address international registries in the future," he adds.

Virtify will be speaking and exhibiting at CBI's 6th Annual Clinical Trial Registration and Results Database conference at Philadelphia, PA on April 27-28.

About Virtify CTRR™

As many of the world's leading life sciences companies support the ongoing push towards greater public advocacy and disclosure, Virtify CTRR enables companies to deploy a future-proof investment that solves today's challenges with the flexibility to maintain compliance as global requirements change. Learn more about Virtify CTRR at www.virtify.com/products/virtify-ctrr.

About Virtify

Virtify is the market leader in Structured Content Management software solutions for life sciences. Organizations rely on Virtify solutions to reduce costs, mitigate risk, and accelerate time-to-market by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle. Virtify's product suite includes software products for Global Labeling, Clinical Trial Disclosure, and Structured Content Management. The company plays a leadership role in the development of global regulatory standards and is an active participant in a variety of standards committees. Virtify's software products combined with comprehensive professional services and deep domain expertise enhance quality and compliance for some of the world's leading life sciences companies.

Learn more about Virtify at www.virtify.com or http://www.linkedin.com/company/virtify-inc.

SOURCE Virtify, Inc.